Anebulo Pharmaceuticals (ANEB) Earnings Date, Estimates & Call Transcripts → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free ANEB Stock Alerts $3.01 +0.01 (+0.33%) (As of 05/10/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryLatest Earnings DateFeb. 13EstimatedActual EPS (Feb. 13) -$0.11 Consensus EPS (Feb. 13) -$0.11 Get Anebulo Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for ANEB and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueANEB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ANEB Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Gold Safe ExchangeGold Set to EXPLODE!Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! Anebulo Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.11)($0.11)($0.11)Q2 20241($0.11)($0.11)($0.11)Q3 20241($0.11)($0.11)($0.11)Q4 20241($0.14)($0.14)($0.14)FY 20244($0.47)($0.47)($0.47)ANEB Earnings Date and InformationAnebulo Pharmaceuticals last posted its earnings results on February 13th, 2024. The reported ($0.11) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.11). Anebulo Pharmaceuticals has generated ($0.42) earnings per share over the last year (($0.42) diluted earnings per share). Earnings for Anebulo Pharmaceuticals are expected to decrease in the coming year, from ($0.47) to ($0.52) per share. Read More Anebulo Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript2/13/2024Q2 2024($0.11)($0.11)-($0.11)--11/14/2023Q1 2024($0.11)($0.10)+$0.01($0.10)--9/20/2023Q4 2023($0.10)($0.10)-($0.10)--5/11/2023Q3 2023-($0.11)($0.11)($0.11)--2/10/2023Q2 2023-($0.15)($0.15)($0.15)--11/10/2022Q1 2023-($0.11)($0.11)($0.11)-- Get the Latest News and Ratings for ANEB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anebulo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 9/9/2022Q4 2022-($0.10)($0.10)($0.10)--5/11/2022Q3 2022-($0.08)($0.08)($0.08)--2/11/2022Q2 2022-($0.05)($0.05)($0.05)-- 11/12/2021Q3 2021($0.11)($0.07)+$0.04($0.07)--9/21/2021Q4($0.03)($1.59)($1.56)$1.33--6/20/2021Q3 2021($0.04)($0.69)($0.65)($0.69)-- Anebulo Pharmaceuticals Earnings - Frequently Asked Questions When did Anebulo Pharmaceuticals announce their last quarterly earnings? Anebulo Pharmaceuticals (NASDAQ:ANEB) last announced its quarterly earning data on Tuesday, February 13, 2024. Learn more on ANEB's earnings history. Did Anebulo Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Anebulo Pharmaceuticals (NASDAQ:ANEB) reported ($0.11) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.11). Learn more on analysts' earnings estimate vs. ANEB's actual earnings. How much profit does Anebulo Pharmaceuticals generate each year? Anebulo Pharmaceuticals (NASDAQ:ANEB) has a recorded net income of -$11.73 million. ANEB has generated -$0.42 earnings per share over the last four quarters. What is Anebulo Pharmaceuticals's EPS forecast for next year? Anebulo Pharmaceuticals's earnings are expected to decrease from ($0.47) per share to ($0.52) per share in the next year. More Earnings Resources from MarketBeat Related Companies: RVPH Earnings LPTX Earnings SLS Earnings AFMD Earnings TPST Earnings LFVN Earnings VTVT Earnings HOOK Earnings JAGX Earnings CRVS Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:ANEB) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anebulo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
